ALVAL Valbiotis SA

0.6361USD0.5800 EUR · EPA+0.87%Mkt Cap: 22.58M USDP/E: —

Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbe…

Key Statistics

Company
Market Cap22.58M USD
Enterprise Value14.43M USD
Revenue (TTM)1.47M USD
Gross Profit-1.45M USD
Net Income (TTM)-10.33M USD
Revenue/Share0.06 USD
Last Price0.6361 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees50
CountryFR
SectorConsumer Defensive
IndustryPackaged Foods
ISINFR0013254851
Valuation
P/E (Trailing)—
P/E (Forward)-3.22
PEG—
EV/EBITDA-1.68
EV/Revenue9.84
P/S15.40
P/B1.64
EPS (TTM)-0.35 USD
EPS (Forward)-0.20 USD
52W Range
0.533012% of range1.421
52W High1.421 USD
52W Low0.5330 USD
Profitability
Gross Margin-146.19%
Oper. Margin-597.53%
EBITDA Margin0.00%
Profit Margin-1040.55%
ROE-135.28%
ROA-65.45%
ROIC-281.33%
ROCE-93.05%
Growth
Revenue Growth129.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.82M USD
CapEx (TTM)165.62K USD
FCF Margin-349.23%
FCF Yield-22.68%
Net Debt-8.15M USD
Net Debt/EBITDA0.95
Net Debt/FCF—
Balance Sheet
Debt/Equity0.73
Current Ratio3.58
Quick Ratio2.85
Book Value/Sh0.39 USD
Cash/Share0.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.481 USD
Upside (mean)+132.8%
Target Range1.426 USD – 1.536 USD
1.426+132.8% to mean1.536
# Analysts2
Ownership
Shares Out.35.49M
Float34.78M
Insiders2.57%
Institutions1.53%
Technical
SMA 500.7044 (-9.7%)
SMA 2000.9447 (-32.7%)
Beta-0.18
S&P 52W Chg12.00%
Avg Vol (30d)147.35K
Avg Vol (10d)72.71K
Technical Indicators
RSI (14)42.3
MACD-0.0099
MACD Signal-0.0075
MACD Hist.-0.0024
BB Upper0.7472 USD
BB Middle0.6745 USD
BB Lower0.6019 USD
BB Width21.53%
ATR (14)0.0428 USD
Vol Ratio (20d)0.44x

About Valbiotis (EPA: ALVAL)

›

Valbiotis (EPA: ALVAL) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 50 employees.

The shares were at 0.5800 EUR on 19 November 2026, down 29.3% over 52 weeks. Its 52-week range is 0.4860 EUR to 1.296 EUR: the price is 55.2% below the high and 19.3% above the low.

Its market capitalisation is 20.58M EUR.

Valbiotis reports return on equity of -135.3% and revenue up 129.7% year over year.

It holds more cash than debt, a net cash position of 7.43M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 2 analysts cover the stock; their mean price target of 1.350 EUR is 132.8% above the current price.